TY - JOUR
T1 - Evidence-based Chinese Medicine Clinical Practice Guideline for Stroke in Hong Kong
AU - Zhong, Linda L.D.
AU - Kun, Wai
AU - Shi, Nannan
AU - Ziea, Tat Chi
AU - Ng, Bacon F.L.
AU - Gao, Ying
AU - Bian, Zhaoxiang
AU - Lu, Aiping
N1 - Funding Information:
The research was financially funded by Hong Kong Hospital Authority Research Project: Chinese Medicine Clinical Practice Guideline in Stroke, Insomnia and Chronic Gastritis (HA820/126/19/19/14/6/12/1). Acknowledgements
Publisher Copyright:
© 2020, The Author(s).
PY - 2020/12/1
Y1 - 2020/12/1
N2 - Background: Stroke in Chinese Medicine (CM) includes the concepts of ischemic and hemorrhagic strokes from Western Medicine and is a common disease in Hong Kong. This clinical practice guideline (CPG) aims to evaluate and demonstrate CM treatment options for stroke, provide guideline for local CM practice, and act as a reference for decision makers on drafting CM related health policies. Methods: Based on the principle of multidisciplinary integration and evidence-based medicine, a steering committee oversaw the CPG development process in accordance with a published protocol. Clinical questions and evidences were identified, appraised, and synthesised through systematic literature reviews, text mining, and two rounds of Delphi surveys with a multidisciplinary panel of experts. Results: In this CPG, we defined stroke from the perspectives of both CM and Western Medicine, reported corresponding CM treatment options, and carried out evaluation based on levels of evidence and grade of recommendation. Suggested CM interventions include herbal medicine treatment based on pattern differentiation, acupuncture treatment, and nursing care. Conclusion: The target population is Hong Kong stroke patients with prodrome or sequela stage. This CPG is intended to help standardizing CM clinical practice and enhancing efficiency of clinical service in Hong Kong.
AB - Background: Stroke in Chinese Medicine (CM) includes the concepts of ischemic and hemorrhagic strokes from Western Medicine and is a common disease in Hong Kong. This clinical practice guideline (CPG) aims to evaluate and demonstrate CM treatment options for stroke, provide guideline for local CM practice, and act as a reference for decision makers on drafting CM related health policies. Methods: Based on the principle of multidisciplinary integration and evidence-based medicine, a steering committee oversaw the CPG development process in accordance with a published protocol. Clinical questions and evidences were identified, appraised, and synthesised through systematic literature reviews, text mining, and two rounds of Delphi surveys with a multidisciplinary panel of experts. Results: In this CPG, we defined stroke from the perspectives of both CM and Western Medicine, reported corresponding CM treatment options, and carried out evaluation based on levels of evidence and grade of recommendation. Suggested CM interventions include herbal medicine treatment based on pattern differentiation, acupuncture treatment, and nursing care. Conclusion: The target population is Hong Kong stroke patients with prodrome or sequela stage. This CPG is intended to help standardizing CM clinical practice and enhancing efficiency of clinical service in Hong Kong.
KW - Acupuncture
KW - Chinese medicine
KW - Clinical practice guideline
KW - Evidence-based medicine
KW - Stroke
UR - http://www.scopus.com/inward/record.url?scp=85094928554&partnerID=8YFLogxK
U2 - 10.1186/s13020-020-00397-9
DO - 10.1186/s13020-020-00397-9
M3 - Journal article
AN - SCOPUS:85094928554
SN - 1749-8546
VL - 15
JO - Chinese Medicine (United Kingdom)
JF - Chinese Medicine (United Kingdom)
IS - 1
M1 - 116
ER -